HomeCGEN • NASDAQ
Compugen Ltd
$2.58
After Hours:
$2.62
(1.55%)+0.040
Closed: Mar 28, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$2.54
Day range
$2.50 - $2.63
Year range
$0.53 - $3.03
Market cap
230.99M USD
Avg Volume
672.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
33.46M346.12%
Operating expense
13.47M33.99%
Net income
9.71M414.13%
Net profit margin
29.03170.41%
Earnings per share
0.11375.00%
EBITDA
18.10M631.11%
Effective tax rate
48.11%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
50.68M-39.19%
Total assets
121.33M28.84%
Total liabilities
55.78M238.11%
Total equity
65.56M
Shares outstanding
89.53M
Price to book
3.48
Return on assets
47.59%
Return on capital
73.98%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
9.71M414.13%
Cash from operations
Cash from investing
Cash from financing
Net change in cash
Free cash flow
About
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big companies such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and Five Prime Therapeutics are among Compugen's competitors. Wikipedia
Founded
Feb 10, 1993
Website
Employees
68
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu